Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News

Medication Management in Older Adults With Cognitive Decline

A qualitative study shows medication management depends on trust, caregiver support, and early recognition of cognitive decline, not memory alone.

A Paper-Free NHS Is a Distant Reality

Four fifths of NHS hospital trusts in England are still using pen and paper for record keeping according to BMJ analysis.

Thrombectomy Shows Late Benefit in Large-Core Stroke: TESLA

One-year TESLA results showed better functional outcomes and quality of life with thrombectomy plus medical management, despite the trial’s neutral 90-day primary endpoint.

Hypertrabeculation in DCM Not Linked to Embolic Event Risk

Left ventricular hypertrabeculation is observed in approximately 30% of patients with dilated cardiomyopathy but is not linked to risk for embolic events.

Protein Intake and Kidney Function: No Link Found

A decade-long study using precise kidney function measurements challenges concerns about dietary protein harming kidney health in adults largely free of chronic kidney disease.

New Journal Aims for Faster, Easier, Free Publication

New journal OpenSource: Cardiology touts itself as a publishing alternative that’s smoother and faster because the entire system was set up by physicians.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Todays Updates

Jazz Seeks Second-Line Lurbinectedin SCLC Withdrawal

The planned label change follows failure of lurbinectedin to improve overall survival in the phase 3 postmarketing trial; the first-line maintenance indication remains unaffected.

Latest News

A qualitative study shows medication management depends on trust, caregiver support, and early recognition of cognitive decline, not memory alone.

Four fifths of NHS hospital trusts in England are still using pen and paper for record keeping according to BMJ analysis.

One-year TESLA results showed better functional outcomes and quality of life with thrombectomy plus medical management, despite the trial’s neutral 90-day primary endpoint.

Left ventricular hypertrabeculation is observed in approximately 30% of patients with dilated cardiomyopathy but is not linked to risk for embolic events.

A decade-long study using precise kidney function measurements challenges concerns about dietary protein harming kidney health in adults largely free of chronic kidney disease.

New journal OpenSource: Cardiology touts itself as a publishing alternative that’s smoother and faster because the entire system was set up by physicians.

News All Time

Short Bursts of Movement in Daily Life May Prevent T2D

Brief, intermittent bouts of moderate- to vigorous-intensity activity in daily routines may lower the risk of developing type 2 diabetes, a prospective analysis of UK Biobank participants shows.

For GLP-1 Patients: Shift Focus From ‘Number of the Scale’

Experts say weight alone should not be the goal of treatment with breakthrough GLP-1s. Cardiovascular health and muscle health must be emphasized.

Autoinjector Offers At-Home Edema Care for HF, CKD Patients

Intravenous-equivalent autoinjector aims to shift edema care out of hospital, offering patients with heart failure and chronic kidney disease a quick, at-home treatment.

Calcium Scores May Refine Risk Estimate and Statin Decisions

Coronary artery calcium scoring may help guide statin decisions by refining heart risk assessment, particularly when the need for treatment is uncertain.

Advanced Heart Failure Mortality Drops in Sweden

Among patients with advanced heart failure and reduced ejection fraction, all-cause and cardiovascular deaths have declined over two decades, but uptake of advanced therapies remains low.

Cushing Linked to Poor Prognosis in Neuroendocrine Neoplasms

Ectopic Cushing syndrome is associated with poor survival and a high burden of severe clinical outcomes in patients with neuroendocrine neoplasms.

Wearable Alerts for Cardiac Arrest in End-of-Life Setting

A photoplethysmography-based wristband detects cardiac arrest with high sensitivity in sedated patients in the ICU after withdrawal of life-sustaining treatment, a study finds.

BP Variability Tied to Cognitive Decline

Visit-to-visit systolic blood pressure fluctuations independently predict accelerated cognitive decline in adults at high cardiovascular risk, a study suggests.

Surviving Cardiogenic Shock: Are Patients Recovering?

Cardiogenic shock survivors continue to experience functional disability and report lower health-related quality of life after hospital discharge.

Is Meal Quality More Important Than Food Processing Level?

Health risks of plant-based diets may depend more on meal quality than levels of food processing, new research suggests.

Can Physicians Ever Switch Off? Five Places to Disconnect

Remote destinations offer physicians a chance to step away from clinical demands, recharge, and enjoy uninterrupted time in some of the world’s most secluded landscapes.

Start Screening Kids for Hypertension at Age 7, Experts Say

One in 11 Australian children experience elevated blood pressure, and new clinical guidelines have been released in a bid to tackle this problem.

Early AKI Prevention Tool Flags Risk, but Compliance Low

A deep learning-based AKI risk assessment strategy triggered early nephrology recommendations, but low adherence and limited perceived urgency may have limited its clinical impact.

GLP-1 Drugs May Be Safe in Opioid Use Disorder

The initiation of GLP-1 receptor agonists is not linked to an increased risk for adverse gastrointestinal, renal, respiratory, or psychiatric outcomes among individuals with opioid use disorder.

To Beat Cigarette Addiction, Experts Embrace Vapes

New expert guidance clears the way for US clinicians to present vapes as a valid option for quitting smoking.

The Coming ‘Tsunami’: Cardiac Effects of Cancer Therapy

New research strengthens the case for using certain medications to help protect some patients from cardiac toxicity — and highlights major knowledge gaps.

Recommended News For You

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

Olaparib-Abiraterone in mCRPCs Selected by Biomarkers Outperforms Each Agent by Itself.

Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

Through the activation of bitter taste receptors, lidocaine has the potential to kill some cancer cells.

Recommended Articles For You

Demystifying Hypereosinophilic Syndrome: Symptoms, Diagnosis, and Treatment Options  

The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough 

Circulating Tumor Cells & Platelet Interactions: Crosstalk for Therapeutic Advances 

Emerging Trends in Oncology for Modern Medicine 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

New imaging solution could help improve survival for patients with recurring prostate cancer

2.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

3.

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

4.

Screening for prostate cancer: is it time to give up digital rectal examination?

5.

Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.

1.

Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy

2.

Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use

3.

Uncovering the Hidden Symptoms of Parathyroid Cancer in Women

4.

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025

5.

Iron Deficiency Anemia: Challenges in Diagnosis and Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Post Progression Approaches After First-line Third-Generaion ALK Inhibitors

2.

Navigating the Complexities of Ph Negative ALL - Part V

3.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

4.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

5.

Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot